martes, 18 de noviembre de 2025

Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use Guidance for Industry November 2025

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-waiver-requests-ph-adjusters-generic-drug-products-intended-parenteral-ophthalmic-or

No hay comentarios: